Oxalic Acid

Oxalic Acid

SCHEMBL5874900

CCN.CCN.O=C(O)C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 3/20 0.47
GLRA1 P23415 1/20 0.47
SLC6A9 P48067 1/20 0.47
OR51E2 Q9H255 1/20 0.47
ALOX15 P16050 2/20 0.46
LDHA P00338 1/20 0.40
LDHB P07195 1/20 0.40
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
TDP1 Q9NUW8 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GABRR1 P24046 4/20 0.36
ACHE P22303 1/20 0.36
LCK P06239 1/20 0.36
FYN P06241 1/20 0.36
GABRR3 A8MPY1 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL5171936 1.00
Bicarbonate SCHEMBL1930707 0.87 FFAR3 (0.50) FFAR3GLRA1SLC6A9OR51E2ALOX15
Bicarbonate SCHEMBL34463191 0.87 FFAR3 (0.50) FFAR3GLRA1SLC6A9OR51E2ALOX15
Bicarbonate SCHEMBL652423 0.87
Oxalic Acid SCHEMBL10594746 0.85 ALOX15 (0.48) FFAR3GLRA1SLC6A9OR51E2ALOX15
Oxalic Acid SCHEMBL2110681 0.85 ALOX15 (0.48) FFAR3GLRA1SLC6A9OR51E2ALOX15
Pyruvate SCHEMBL21145119 0.85
Oxalic Acid SCHEMBL27329110 0.85 ALOX15 (0.48) FFAR3GLRA1SLC6A9OR51E2ALOX15
Acetic Acid SCHEMBL7880095 0.83 FFAR3 (0.58) FFAR3GLRA1SLC6A9OR51E2ALOX15
Acetic Acid SCHEMBL10766537 0.83 FFAR3 (0.58) FFAR3GLRA1SLC6A9OR51E2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025075046-A1 ANALYSIS METHOD 株式会社ダイセル 2025-04-10 WO disclosed
CN-108689862-B Process for preparing ethanitramine 西安近代化学研究所 2021-02-26 CN disclosed
CN-108484432-B Method for synthesizing ethanitramine 西安近代化学研究所 2021-02-26 CN disclosed
CN-108558696-B Preparation method of ethanitramine 西安近代化学研究所 2021-02-23 CN disclosed
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 US disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
CN-103943363-A Electrolyte of aluminum electrolytic capacitor, preparation method thereof and aluminum electrolytic capacitor FENGHUA ADVANCED TECHNOLOGY HOLDING CO LTD 2014-07-23 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 FFAR3 2270/4885GLRA1 2349/4885SLC6A9 1559/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK FFAR3 1837/4885GLRA1 1100/4885SLC6A9 2404/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA FFAR3 3218/4885GLRA1 2165/4885SLC6A9 737/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 FFAR3 2914/4885GLRA1 2675/4885SLC6A9 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.